Clinical Trial

CoCrMo LOCK Bipolar Femoral Heads FU

Recruiting
View on ClinicalTrials.gov →
Summary
Study design: monocentric, retrospective, observational and post-market clinical study. Purpose: To demonstrate the safety and performance of CoCrMo LOCK bipolar femoral heads. The eligible study population is represented by the entire population that underwent a hip replacement with CoCrMo LOCK bipolar femoral heads from 1st January 2023 onwards at the site in accordance with the indication for use of the product.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-17; most recent amendment 2026-07-03.
Status change: Not Yet Recruiting → Recruiting 2026-07-03
Trial Details
NCT Number NCT06885359
Lead Sponsor Limacorporate S.p.a
Conditions Femoral Fractures, Hip Arthropathy
Enrollment 60 participants
Start Date 2026-01-28
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-07